Popular weight loss injectable removed from US markets
The U.S. Food and Drug Administration announced the recall of several batches of the weight loss drug "Tersepatide," which is used by pharmaceutical companies, due to potential product contamination. This step comes after the detection of possible safety risks and emphasizes the importance of monitoring the quality and manufacturing methods of weight management products. No reports of direct injuries have been issued so far, and investigations are ongoing to determine the extent of the contamination's danger to users.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)